Malzahn Craig has filed 4 insider transactions across 1 company since September 2025.
Most recent transaction: a grant/award of 65847 shares of REGENXBIO Inc. ($RGNX) on January 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | REGENXBIO Inc. | $RGNX | Malzahn Craig | Chief Technology Officer | A | Common Stock | 65847 | $0.00 | 82,194.0000 | 51,689,000 | 402.81% | 0.13% |
| Jan. 6, 2026 | REGENXBIO Inc. | $RGNX | Malzahn Craig | Chief Technology Officer | A | Stock Options (Right to buy) | 35402 | $0.00 | 35,402.0000 | 51,689,000 | 9999.99% | 0.07% |
| Jan. 2, 2026 | REGENXBIO Inc. | $RGNX | Malzahn Craig | Chief Technology Officer | F | Common Stock | 1238 | $14.40 | 16,347.0000 | 51,689,000 | 7.04% | 0.00% |
| Sept. 1, 2025 | REGENXBIO Inc. | $RGNX | Malzahn Craig | Chief Technology Officer | F | Common Stock | 234 | $8.93 | 17,585.0000 | 49,509,000 | 1.31% | 0.00% |